London: Cholesterol-lowering drugs continue to produce benefits without any serious safety problems, such as increased cancer risk, even after more than a decade of use, researchers said Wednesday.
Pak asks for DGMO meet with India to address border firing
Communal violence on rise in BJP rule: Mayawati
CCTV captures chain snatcher at Wadala station
SC refuses to postpone UPSC preliminary examination